Priapism in sickle cell anemia in Togo: prevalence and knowledge of this complication.
Prevalence of priapism and knowledge on this disease was assessed by interviewing a group of 114 sickle cell anemia patients, 5 years and older, considered to be genotypically homogenous (Benin or #19 haplotype). Prevalence of priapism in homozygous sickle cell patients was 26.3% (30/114) and that of the control group of subjects with Hb AA was 2% (2/102) (the difference was very significant: p = 5.10-7). Actuarial probability of having priapism by 20 years of age was 69 +/- 8.5%. Few homozygous patients without a history of priapism (15.8%) have heard about priapism. This lack of knowledge, added to low accessibility of a health care system, may explain the high rate of impotence (31.6%). The results of this study led us to plan a large program of infonnation about priapism and sickle cell disease in the Togolese population.
Gbadoé
A D
AD
Department of Pediatrics, Infectiology BP8881, University of Lomé, Togo. adgbadoe@tg.refer.org
Dogba
A
A
Ségbéna
A Y
AY
Nyadanu
M
M
Atakouma
Y
Y
Kusiaku
K
K
Vovor
A
A
Assimadi
J K
JK
D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D017668:Age of Onset; D000755:Anemia, Sickle Cell / Q000150:complications*; D016022:Case-Control Studies; D002648:Child; D003625:Data Collection; D007722:Health Knowledge, Attitudes, Practice; D006720:Homozygote; D006801:Humans; D008297:Male; D015995:Prevalence; D011317:Priapism / Q000453:epidemiology* / Q000209:etiology*; D014037:Togo / Q000453:epidemiology